Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma
Alexander M M Eggermont, Stefan Suciu, Alessandro Testori, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 17, 2021
Molecular immuno-imaging improves tumor detection in head and neck cancer
Jing-Hui Li, Reza Forghani, Lionel Bure, et al.
Journal for Immunotherapy of Cancer
|
November 22, 2017
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
Rahima Jamal, Réjean Lapointe, Eftihia Cocolakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial
Alexander M M Eggermont, Stefan Suciu, Piotr Rutkowski, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 27, 2020
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
Peter C Black, Nimira S Alimohamed, David Berman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
Wim H J Kruit, Stefan Suciu, Brigitte Dreno, et al.
Molecular Cancer Therapeutics
|
June 28, 2019
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes
Mathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay, et al.
Cancer Treatment and Research Communications
|
March 23, 2023
Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre
Mark Sorin, Sophie Camilleri-Broët, Emilie Pichette, et al.
Cancers
|
August 7, 2021
Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models
Xiaoyang Liu, Farhad Maleki, Nikesh Muthukrishnan, et al.
Pigment Cell & Melanoma Research
|
September 30, 2010
Genetic and morphologic features for melanoma classification
Sigrid M C Broekaert, Ritu Roy, Ichiro Okamoto, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma
Alexander M M Eggermont, Stefan Suciu, Alessandro Testori, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 17, 2021
Molecular immuno-imaging improves tumor detection in head and neck cancer
Jing-Hui Li, Reza Forghani, Lionel Bure, et al.
Journal for Immunotherapy of Cancer
|
November 22, 2017
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
Rahima Jamal, Réjean Lapointe, Eftihia Cocolakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial
Alexander M M Eggermont, Stefan Suciu, Piotr Rutkowski, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 27, 2020
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
Peter C Black, Nimira S Alimohamed, David Berman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
Wim H J Kruit, Stefan Suciu, Brigitte Dreno, et al.
Molecular Cancer Therapeutics
|
June 28, 2019
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes
Mathilde Couëtoux du Tertre, Maud Marques, Lise Tremblay, et al.
Cancer Treatment and Research Communications
|
March 23, 2023
Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre
Mark Sorin, Sophie Camilleri-Broët, Emilie Pichette, et al.
Cancers
|
August 7, 2021
Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models
Xiaoyang Liu, Farhad Maleki, Nikesh Muthukrishnan, et al.
Pigment Cell & Melanoma Research
|
September 30, 2010
Genetic and morphologic features for melanoma classification
Sigrid M C Broekaert, Ritu Roy, Ichiro Okamoto, et al.
Page
of 8